Wolverine Trading
MED icon

Wolverine Trading’s Medifast MED Stock Holding History

Wolverine Trading’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,044
Closed -$180K – 5257
2025
Q1 		$180K Sell
13,044
-8,117
-38% -$122K ﹤0.01% 3999
2024
Q4 		$376K Buy
+21,161
New +$393K ﹤0.01% 3749
2024
Q3 		– Sell
-12,184
Closed -$235K – 5148
2024
Q2 		$266K Buy
+12,184
New +$325K ﹤0.01% 3529
2021
Q4 		– Sell
-1,478
Closed -$306K – 6457
2021
Q3 		$293K Sell
1,478
-387
-21% -$95.1K ﹤0.01% 4743
2021
Q2 		$521K Buy
1,865
+774
+71% +$210K ﹤0.01% 3624
2021
Q1 		$233K Buy
+1,091
New +$261K ﹤0.01% 4838
2019
Q3 		– Sell
-18,006
Closed -$2.31M – 4764
2019
Q2 		$2.31M Buy
18,006
+1,856
+11% +$258K 0.01% 1392
2019
Q1 		$2.06M Buy
16,150
+253
+2% +$32.1K 0.01% 1513
2018
Q4 		$1.97M Buy
15,897
+11,065
+229% +$1.89M 0.01% 1425
2018
Q3 		$1.07M Sell
4,832
-2,405
-33% -$488K ﹤0.01% 2285
2018
Q2 		$676K Hold
7,237
– – ﹤0.01% 2688
2018
Q1 		$676K Sell
7,237
-2,151
-23% -$161K ﹤0.01% 2688
2017
Q4 		$655K Buy
+9,388
New +$623K ﹤0.01% 2678

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wolverine Trading's MED Position: Q2 2025 in Review

Wolverine Trading sold out of Medifast (MED) in Q2 2025, closing a stake of 13,044 shares — an estimated $180K sold.

Wolverine Trading first reported a position in MED in Q4 2017 and held it in 13 quarters. The position peaked at $2.31M in Q2 2019. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Wolverine Trading reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 13,044 Medifast shares in Q2 2025, an estimated $180K.
  • Wolverine Trading first reported a position in Medifast in Q4 2017 and held it in 13 quarters.
  • Wolverine Trading's Medifast position peaked at $2.31M in Q2 2019.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.